Hancock Whitney’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-16,256
Closed -$901K 591
2016
Q2
$901K Sell
16,256
-14,301
-47% -$788K 0.04% 333
2016
Q1
$1.63K Buy
30,557
+12,817
+72% +$631K 0.07% 262
2015
Q4
$913K Sell
17,740
-902
-5% -$44.8K 0.04% 321
2015
Q3
$842K Sell
18,642
-588
-3% -$27.8K 0.04% 312
2015
Q2
$825K Hold
19,230
0.03% 312
2015
Q1
$825K Buy
19,230
+1,007
+6% +$38.4K 0.03% 312
2014
Q4
$633K Sell
18,223
-29,285
-62% -$972K 0.02% 362
2014
Q3
$1.54M Buy
47,508
+16,854
+55% +$564K 0.06% 247
2014
Q2
$1.04M Buy
30,654
+2,001
+7% +$64.1K 0.04% 295
2014
Q1
$781K Buy
28,653
+96
+0.3% +$2.85K 0.03% 303
2013
Q4
$1.02M Sell
28,557
-3,338
-10% -$111K 0.04% 279
2013
Q3
$961K Sell
31,895
-859
-3% -$28.1K 0.04% 278
2013
Q2
$954K Buy
+32,754
New +$923K 0.05% 269

Other funds holding PBH

Hancock Whitney's PBH Position: Q3 2016 in Review

Hancock Whitney sold out of Prestige Consumer Healthcare (PBH) in Q3 2016, closing a stake of 16,256 shares — an estimated $901K sold.

Hancock Whitney first reported a position in PBH in Q2 2013 and held it in 13 quarters. The position peaked at $1.54M in Q3 2014. 243 funds tracked by Wall St. Rank hold PBH as of Q3 2016.

  • Hancock Whitney reported no remaining Prestige Consumer Healthcare position as of Q3 2016 after selling out during the quarter.
  • Hancock Whitney sold 16,256 Prestige Consumer Healthcare shares in Q3 2016, an estimated $901K.
  • Hancock Whitney first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 13 quarters.
  • Hancock Whitney's Prestige Consumer Healthcare position peaked at $1.54M in Q3 2014.
  • 243 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2016.

Based on Hancock Whitney's 13F filing for Q3 2016, filed 9 Nov 2016.